Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic-Naïve Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease
Clin. Gastroenterol. Hepatol. 2021 Apr 07;[EPub Ahead of Print], N Narula, ECL Wong, PS Dulai, NK Sengupta, JK Marshall, JF Colombel, W ReinischFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.